Last reviewed · How we verify
Saliva sampling
At a glance
| Generic name | Saliva sampling |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Analytical Evaluation of the Endotest® Diagnostic (NA)
- Impact of Ziwig Endotest® on the Management of Patients With Clinical Symptoms of Endometriosis Inconsistent With Their Imaging Work-up (NA)
- PICU-related Sleep and Circadian Dysregulation Pilot Study (NA)
- Microbiota and the Lung Cancer (NA)
- Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
- Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
- Salivary Biomarkers for Concussion
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Saliva sampling CI brief — competitive landscape report
- Saliva sampling updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI